Cellular Biomedicine Group, Inc. (Nasdaq: CBMG) (“Company,” “CBMG,” “we” or “our”), a biopharmaceutical firm engaged in the drug development of immunotherapies for cancer and stem cell therapies for degenerative diseases, announced today that it has signed a definitive merger agreement to be acquired by a newly-formed entity (“Parent”) formed on behalf of a consortium.
Read the full article: Cellular Biomedicine Group (CBMG) Enters into Definitive Merger Agreement //
Source: https://www.prnewswire.com/news-releases/cellular-biomedicine-group-cbmg-enters-into-definitive-merger-agreement-transaction-would-result-in-company-going-private-301110737.html